# Asure Software Inc: overview

ASUR · Nasdaq · CIK 884144 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asur.md) · [Financials](/companies/asur/financials.md) · [Filings](/companies/asur/filings.md) · [Insiders](/companies/asur/insiders.md)

Latest reported revenue: [$40.0m](/filings/0001628280-26-068268.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-068268).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [34.9](/filings/0001628280-26-028860.md) | [30.1](/filings/0001628280-26-051066.md) | [36.3](/filings/0001628280-26-068268.md) | not reported | [42.8](/filings/0001628280-26-028860.md) | [37.1](/filings/0001628280-26-051066.md) | [40.0](/filings/0001628280-26-068268.md) |
| Gross margin | % | not reported | [70.6%](/filings/0001628280-26-028860.md) | [66.1%](/filings/0001628280-26-051066.md) | [64.9%](/filings/0001628280-26-068268.md) | not reported | [71.3%](/filings/0001628280-26-028860.md) | [67.5%](/filings/0001628280-26-051066.md) | [69.6%](/filings/0001628280-26-068268.md) |
| Operating margin | % | not reported | [(5.8%)](/filings/0001628280-26-028860.md) | [(15.4%)](/filings/0001628280-26-051066.md) | [(9.7%)](/filings/0001628280-26-068268.md) | not reported | [5.4%](/filings/0001628280-26-028860.md) | [(6.5%)](/filings/0001628280-26-051066.md) | [1.3%](/filings/0001628280-26-068268.md) |
| Net margin | % | not reported | [(6.9%)](/filings/0001628280-26-068268.md) | [(20.3%)](/filings/0001628280-26-068268.md) | [(14.8%)](/filings/0001628280-26-068268.md) | not reported | [1.5%](/filings/0001628280-26-068268.md) | [(12.0%)](/filings/0001628280-26-068268.md) | [(1.5%)](/filings/0001628280-26-068268.md) |
| Diluted EPS | $ per share | not reported | [(0.09)](/filings/0001628280-26-028860.md) | [(0.22)](/filings/0001628280-26-051066.md) | [(0.19)](/filings/0001628280-26-068268.md) | not reported | [0.02](/filings/0001628280-26-028860.md) | [(0.15)](/filings/0001628280-26-051066.md) | [(0.02)](/filings/0001628280-26-068268.md) |
| Free cash flow | $m | [9.6 d](/filings/0001628280-26-012270.md) | [1.8](/filings/0001628280-26-028860.md) | [3.0 d](/filings/0001628280-26-051066.md) | [5.6 d](/filings/0001628280-26-068268.md) | [11.0 d](/filings/0001628280-26-012270.md) | [2.5](/filings/0001628280-26-028860.md) | [4.2 d](/filings/0001628280-26-051066.md) | [5.5 d](/filings/0001628280-26-068268.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [76.1](/filings/0000884144-23-000012.md) | [95.8](/filings/0000884144-24-000022.md) | [119](/filings/0000884144-24-000022.md) | not reported | not reported |
| Gross margin | % | [61.2%](/filings/0000884144-23-000012.md) | [65.2%](/filings/0000884144-24-000022.md) | [71.8%](/filings/0000884144-25-000012.md) | not reported | not reported |
| Operating margin | % | [(17.0%)](/filings/0000884144-23-000012.md) | [(11.8%)](/filings/0000884144-24-000022.md) | [(2.5%)](/filings/0000884144-25-000012.md) | not reported | not reported |
| Net margin | % | [4.2%](/filings/0000884144-23-000012.md) | [(15.1%)](/filings/0000884144-24-000022.md) | [(7.7%)](/filings/0000884144-25-000012.md) | not reported | not reported |
| Diluted EPS | $ per share | [0.16](/filings/0000884144-23-000012.md) | [(0.72)](/filings/0000884144-24-000022.md) | [(0.42)](/filings/0000884144-25-000012.md) | [(0.45)](/filings/0001628280-26-012270.md) | [(0.48)](/filings/0001628280-26-012270.md) |
| Free cash flow | $m | [1.2](/filings/0000884144-23-000012.md) | [11.4](/filings/0000884144-24-000022.md) | [17.3](/filings/0000884144-25-000012.md) | [8.7](/filings/0001628280-26-012270.md) | [21.4](/filings/0001628280-26-012270.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/asur/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Private Capital Management, LLC](/funds/1588456.md) | 2026-06-30 | $33.4m | 4,203,526 |  | Added +191,468 |
| [NEEDHAM INVESTMENT MANAGEMENT LLC](/funds/1167212.md) | 2026-06-30 | $20.9m | 2,635,000 |  | Added +27,500 |
| [JANUS HENDERSON GROUP PLC](/funds/1274173.md) | 2026-03-31 | $15.2m | 1,769,578 |  | Not compared |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $14.5m | 1,830,824 |  | Not compared |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $13.1m | 1,651,498 |  | Added +139,634 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.5m | 1,070,718 |  | Reduced −16,162 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $7.6m | 953,880 |  | Reduced −5,564 |
| [Swedbank AB](/funds/946431.md) | 2026-06-30 | $6.4m | 800,000 |  | Unchanged |
| [RICE HALL JAMES & ASSOCIATES, LLC](/funds/1230765.md) | 2026-06-30 | $5.6m | 705,628 |  | Added +34,684 |
| [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $5.5m | 696,002 |  | Reduced −5,776 |

## Recent filings

[All 909 filings](/companies/asur/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:22 ET | [8-K](/filings/0001628280-26-068272.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-068272 |
| 2026-10-29 | 16:21 ET | [10-Q](/filings/0001628280-26-068268.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068268 |
| 2026-10-16 | 16:15 ET | [8-K](/filings/0001104659-26-116616.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-116616 |
| 2026-07-30 | 16:23 ET | [8-K](/filings/0001628280-26-051077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051077 |
| 2026-07-30 | 16:16 ET | [10-Q](/filings/0001628280-26-051066.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051066 |
| 2026-05-13 | 17:45 ET | [8-K](/filings/0001628280-26-034245.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-034245 |
| 2026-04-30 | 16:07 ET | [8-K](/filings/0001628280-26-028869.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028869 |
| 2026-04-30 | 16:05 ET | [10-Q](/filings/0001628280-26-028860.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028860 |
| 2026-04-02 | 16:06 ET | [DEF 14A](/filings/0001628280-26-023137.md) | Proxy statement, period 2026-03-16 | 0001628280-26-023137 |
| 2026-02-26 | 16:14 ET | [8-K](/filings/0001628280-26-012293.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-012293 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-012270.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/eb3e8daf-0088-44b8-81bb-210f0c6c3e1c)

## About the filer

- CIK: 884144
- Tickers: ASUR
- Exchange: Nasdaq
- SIC code: 7373 Services-Computer Integrated Systems Design
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:27 ET. No prices; not investment advice.